Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Daily chlorhexidine bathing and hospital-acquired infection.

Climo MW, Wong ES.

N Engl J Med. 2013 Jun 13;368(24):2332. doi: 10.1056/NEJMc1304820. No abstract available.

PMID:
23758244
2.

Effect of daily chlorhexidine bathing on hospital-acquired infection.

Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES.

N Engl J Med. 2013 Feb 7;368(6):533-42. doi: 10.1056/NEJMoa1113849. Erratum in: N Engl J Med. 2013 Jun 13;368(24):2341.

3.

Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention.

Cosgrove SE, Seo SK, Bolon MK, Sepkowitz KA, Climo MW, Diekema DJ, Speck K, Gunaseelan V, Noskin GA, Herwaldt LA, Wong E, Perl TM; CDC Prevention Epicenter Program.

Infect Control Hosp Epidemiol. 2012 Apr;33(4):374-80. doi: 10.1086/664771.

PMID:
22418633
4.

USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?

Kreisel KM, Stine OC, Johnson JK, Perencevich EN, Shardell MD, Lesse AJ, Gordin FM, Climo MW, Roghmann MC.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):285-90. doi: 10.1016/j.diagmicrobio.2011.03.010. Epub 2011 May 10.

5.

Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremia.

Kreisel KM, Johnson JK, Stine OC, Shardell MD, Perencevich EN, Lesse AJ, Gordin FM, Climo MW, Roghmann MC.

Emerg Infect Dis. 2010 Sep;16(9):1419-27. doi: 10.3201/eid1609.091802.

6.

The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.

Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES.

Crit Care Med. 2009 Jun;37(6):1858-65. doi: 10.1097/CCM.0b013e31819ffe6d.

PMID:
19384220
7.

Decreasing MRSA infections: an end met by unclear means.

Climo MW.

JAMA. 2009 Feb 18;301(7):772-3. doi: 10.1001/jama.2009.149. No abstract available.

PMID:
19224756
8.

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.

Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB.

Am J Infect Control. 2007 Mar;35(2):73-85.

9.

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.

Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB; Society for Healthcare Epidemiology of America; Association of Professionals in Infection Control and Epidemiology.

Infect Control Hosp Epidemiol. 2007 Mar;28(3):249-60. Epub 2007 Feb 7.

PMID:
17326014
10.
11.

Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units.

Huang SS, Rifas-Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES, Cosgrove SE, Perl TM, Pottinger JM, Herwaldt LA, Jernigan JA, Tokars JL, Diekema DJ, Hinrichsen VL, Yokoe DS, Platt R; Centers for Disease Control and Prevention Epicenters Program.

J Infect Dis. 2007 Feb 1;195(3):330-8. Epub 2006 Dec 27.

PMID:
17205470
12.
13.

A multicenter intervention to prevent catheter-associated bloodstream infections.

Warren DK, Cosgrove SE, Diekema DJ, Zuccotti G, Climo MW, Bolon MK, Tokars JI, Noskin GA, Wong ES, Sepkowitz KA, Herwaldt LA, Perl TM, Solomon SL, Fraser VJ; Prevention Epicenter Program.

Infect Control Hosp Epidemiol. 2006 Jul;27(7):662-9. Epub 2006 Jun 9.

PMID:
16807839
14.

Duration of colonization with methicillin-resistant Staphylococcus aureus among patients in the intensive care unit: implications for intervention.

Ridenour GA, Wong ES, Call MA, Climo MW.

Infect Control Hosp Epidemiol. 2006 Mar;27(3):271-8. Epub 2006 Feb 28.

PMID:
16532415
15.

Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program.

Warren DK, Yokoe DS, Climo MW, Herwaldt LA, Noskin GA, Zuccotti G, Tokars JI, Perl TM, Fraser VJ.

Infect Control Hosp Epidemiol. 2006 Jan;27(1):8-13. Epub 2006 Jan 6.

PMID:
16418980
16.

Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin.

Mongodin E, Finan J, Climo MW, Rosato A, Gill S, Archer GL.

J Bacteriol. 2003 Aug;185(15):4638-43.

17.

mecA-blaZ corepressors in clinical Staphylococcus aureus isolates.

Rosato AE, Kreiswirth BN, Craig WA, Eisner W, Climo MW, Archer GL.

Antimicrob Agents Chemother. 2003 Apr;47(4):1460-3.

19.
20.
21.

Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.

Climo MW, Ehlert K, Archer GL.

Antimicrob Agents Chemother. 2001 May;45(5):1431-7.

22.

Staphylococcus aureus bacteremia--consider the source.

Archer GL, Climo MW.

N Engl J Med. 2001 Jan 4;344(1):55-6. No abstract available.

PMID:
11136962
23.

Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.

Franchi D, Climo MW, Wong AH, Edmond MB, Wenzel RP.

Clin Infect Dis. 1999 Dec;29(6):1566-8.

PMID:
10585815
24.
25.
26.

Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost.

Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM.

Ann Intern Med. 1998 Jun 15;128(12 Pt 1):989-95.

PMID:
9625685
27.

Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.

Climo MW, Patron RL, Goldstein BP, Archer GL.

Antimicrob Agents Chemother. 1998 Jun;42(6):1355-60.

28.
29.

Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.

Climo MW, Markowitz SM, Williams DS, Hale-Cooper CG, Archer GL.

J Antimicrob Chemother. 1997 Jul;40(1):59-66.

PMID:
9249205
30.

An outbreak of Pseudomonas aeruginosa related to contaminated urodynamic equipment.

Climo MW, Pastor A, Wong ES.

Infect Control Hosp Epidemiol. 1997 Jul;18(7):509-10.

PMID:
9247835
32.

Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.

Gillum JG, Israel DS, Scott RB, Climo MW, Polk RE.

Antimicrob Agents Chemother. 1996 Jul;40(7):1715-6.

33.

Antimicrobial susceptibility of coagulase-negative staphylococci.

Archer GL, Climo MW.

Antimicrob Agents Chemother. 1994 Oct;38(10):2231-7. Review. No abstract available.

Supplemental Content

Loading ...
Support Center